Cathy Gwin
Senior Director, Communications
NTI and the Vienna Center for Disarmament and Nonproliferation (VCDNP) co-hosted a meeting on June 7, 2022 to explore the possibility of establishing a new “Joint Assessment Mechanism” to strengthen UN-system capabilities to investigate high-consequence biological events of unknown origin.
In a new article for the CTC Sentinel, NTI | bio Vice President Jaime Yassif explains how advances in bioscience and biotechnology are accompanied by emerging biological risks and cites the need for action to safeguard the life sciences to prevent biotechnology catastrophe.
Following the recent detection of monkeypox cases across multiple countries, NTI’s report on the exercise has appeared in a number social media outlets, noting that the associated fictional scenario featured a monkeypox outbreak with a start date that roughly coincides with the current, ongoing outbreak.
NTI | bio and the World Economic Forum (WEF) convened the third annual meeting of the Technical Consortium on DNA Synthesis Screening on May 12-13, 2022.
NTI joined governments and organizations from around the world for the 2nd Global COVID-19 Summit on May 12, 2022 and committed to provide $35,000 to the pandemic preparedness and global health security financial intermediary fund.
Sign up for our newsletter to get the latest on nuclear and biological threats.
Sign up for regular updates on innovative, real-world solutions to existential threats.
{ location = 'https://www.nti.org/get-updates/' }, 300);">Get Updates